货号:A474017
同义名:
Baicalein-7-O-Glucoside
Oroxin A是Oroxylum indicum(大戟科)的种子提取物(OISE)中的主要成分,通过与PPARγ蛋白的配体结合域结合,激活过氧化物酶体增殖物激活受体γ(PPARγ)。Oroxin A 具有抑制α-葡萄糖苷酶的活性,并展现抗氧化能力。Oroxin A 通过诱导内质网应激介导的衰老效应,表现出抗乳腺癌作用。


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 产品名称 | PPARα ↓ ↑ | PPARβ/δ ↓ ↑ | PPARγ ↓ ↑ | PPARδ ↓ ↑ | 其他靶点 | 纯度 | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fenofibric acid | ✔ | 98% | |||||||||||||||||
| GW6471 |
++
PPARα, IC50: 0.24 μM |
99%+ | |||||||||||||||||
| GSK3787 |
++
PPARδ, pIC50: 6.6 |
++
PPARδ, pIC50: 6.6 |
99%+ | ||||||||||||||||
| FH535 | ✔ | 98%+ | |||||||||||||||||
| GW9662 |
+++
PPARα, IC50: 32 nM |
+++
PPARγ, IC50: 3.3 nM |
98% | ||||||||||||||||
| T0070907 |
++++
PPARγ, IC50: 1 nM |
98% | |||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| Concentration | Treated Time | Description | References | |
| HT22 cells | 5 µM | 48 h | To evaluate the protective effect of Oroxin A on neuronal damage in the SAH model. Results showed that Oroxin A significantly alleviated hemin-induced neuronal injury and inhibited ferroptosis. | J Neuroinflammation. 2024 May 3;21(1):116. |
| HepG2 cells | 5 μM or 50 μM | 24 h | Oroxin A reduced lipid accumulation in oleic acid-induced HepG2 cells, decreased cellular TG and TC levels, and inhibited the transcriptional activity of SREBP1 and SREBP2. | Heliyon. 2024 Apr 3;10(7):e29168. |
| HT22 cells | 5 µM | 48 h | To evaluate the neuroprotective effects of Oroxin A on HT22 cells in the SAH model. Results showed that Oroxin A significantly alleviated hemin-induced neuronal injury and inhibited ferroptosis. | J Neuroinflammation. 2024 May 3;21(1):116. |
| Administration | Dosage | Frequency | Description | References | ||
| C57BL/6 mice | Subarachnoid hemorrhage (SAH) model | Tail vein injection | 5 mg/kg | Single dose, observed for 48 hours | To evaluate the protective effect of Oroxin A on early brain injury after SAH. Results showed that Oroxin A significantly improved survival rates, neurological functions, mitigated neuronal death and brain edema, and attenuated the inflammatory response. | J Neuroinflammation. 2024 May 3;21(1):116. |
| Sprague-Dawley rats | High-fat diet-induced lipid metabolism disorder model | Oral gavage | 50 mg/kg or 200 mg/kg | Once daily for 3 months | Oroxin A improved disordered lipid metabolism in high-fat diet-fed non-insulin-resistant rats, reduced plasma and hepatic lipid levels, and enhanced the lipid-lowering effect of atorvastatin. | Heliyon. 2024 Apr 3;10(7):e29168. |
| C57BL/6 mice | Subarachnoid hemorrhage (SAH) model | Tail vein injection | 5 mg/kg | Single dose, observed for 48 hours | To evaluate the neuroprotective effects of Oroxin A in the SAH model. Results showed that Oroxin A significantly improved survival rates, enhanced neurological functions, mitigated neuronal death and brain edema, and attenuated the inflammatory response. | J Neuroinflammation. 2024 May 3;21(1):116. |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
2.31mL 0.46mL 0.23mL |
11.56mL 2.31mL 1.16mL |
23.13mL 4.63mL 2.31mL |
|
| CAS号 | 57396-78-8 |
| 分子式 | C21H20O10 |
| 分子量 | 432.38 |
| SMILES Code | O=C1C=C(C2=CC=CC=C2)OC3=C1C(O)=C(O)C(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O4)=C3 |
| MDL No. | MFCD22125001 |
| 别名 | Baicalein-7-O-Glucoside |
| 运输 | 蓝冰 |
| InChI Key | IPQKDIRUZHOIOM-IAAKTDFRSA-N |
| Pubchem ID | 5320313 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Keep in dark place, sealed in dry, 2-8°C |
| 溶解方案 |
DMSO: 120 mg/mL(277.54 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1